SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
World progress on child and maternal health measured
Fri September 20th - The world has made substantial improvements in child and maternal health this century, according to a major analysis. More
Child gene screening points to adult cancer drugs
Fri September 20th - Genetic screening of children with tumours can point to unexpected treatments, according to the findings of a UK project. More
RECENT COMMENTS
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...
BOOKS ON WOMEN'S HEALTH
guide to breast disorders guide to womb disorders guide to menopause Complete Women's Health: from The Royal College of Obstetricians and Gynaecologists For books and family gift ideas click here
OTHER NEWS OF INTEREST
WOMEN'S HEALTH NEWS FEED
RSS graphic XML Graphic
ENGLEMED HEALTH NEWS

HRT cancer link "not new"

Friday August 30th, 2019

Women who take menopausal hormone therapy face a significantly increased risk of developing breast cancer, according to the findings of a major study published today.

Researchers found that among women who took oestrogen with daily progestogen 2% extra developed breast cancer by the age of 70.

They studied the effect of taking treatments from the age of 50.

The research, published in The Lancet, found that among those who took oestrogen with intermittent progestogen, there were one in 70 extra cases of breast cancer.

When the treatment was only oestrogen, the proportion developing breast cancer increased by 0.5%.

The only treatment not linked to increased risk was topical vaginal oestrogen.

The findings come from an analysis of 100,000 women involved in 58 epidemiological studies around the world between 1992 and 2018.

Use of menopausal hormone treatments halved at the beginning of the century following early studies – but has since stabilised.

Researcher Professor Valerie Beral, from the University of Oxford, UK, said: "Our new findings indicate that some increased risk persists even after stopping use of menopausal hormone therapy. Previous estimates of risks associated with use of menopausal hormone therapy are approximately doubled by the inclusion of the persistent risk after use of the hormones ceases."

The UK Royal College of Obstetricians and Gynaecologists said the conclusions were "not new."

Vice-president Professor Janice Rymer said: “The findings from this research should be helpful to both women and doctors, particularly around when considering whether to start hormone therapy, for how long and which preparation they could take – whether it includes oestrogen and progestagen combined, or oestrogen alone. These findings should not put women off taking HRT if the benefits – such as protection of bones and decrease in cardiovascular risk – outweigh the risks.

“To put the risk into context, a woman has greater risk of developing breast cancer if she is overweight or obese compared to taking HRT. Women must be aware of the effect of obesity and alcohol which increase the risk of breast cancer and modifies the additional risk of HRT.”

UK Royal College of GPs vice-chair Professor Martin Marshall said: “The link between HRT and an increased risk of breast cancer has been known for some time. But it is a complex relationship, and only relates to preparations of HRT that contain certain progestogens - the addition of which is necessary for women who have not had a hysterectomy - and it appears that some combined HRT preparations have a higher breast cancer risk than others.

“This research highlights the importance of taking a holistic approach to prescribing, considering all the different factors potentially affecting an individual’s health and wellbeing, which is what GPs are highly trained to do. It also demonstrates how vital it is that patients are involved in decision-making about their health, fully-informed about the various risks and benefits associated with a treatment."

Dr Julie Sharp, from Cancer Research UK, said: “It’s important to put the risk in perspective – HRT causes 1,400 cancers a year in the UK, which is less than 1% of cases. We need high quality, accurate information on the long-term effects of using HRT, which is why we’ve funded this research; women have to know the risks of which type of HRT they take and how long they take it for to decide what’s right for them."

Lancet 30 August 2019

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)31709-X/fulltext

Tags: Cancer | Pharmaceuticals | UK News | Women's Health & Gynaecology

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES